Management of type 1 diabetes (T1D) in adolescents requires special consideration. Treatment regimens need to take account of the physical and physiologic changes occurring in this age-group—including ...

Twice-Daily Use of Biphasic Insulin Aspart 30 (BIAsp 30): Comparative Studies A total of seven publications (three papers and four abstracts) from five studies were identified that compared ...

Major diabetes study included 52,419 patients from Poland, Russia, Greece, Italy, Canada, China, India and Japan. 53% achieved blood glucose target of less than 7% set by International Diabetes ...

Bagsværd, Denmark, 1 September 2014 - Novo Nordisk today announced that in Mexico, as the first country in the world, Ryzodeg® is now launched and made available for people with type 2 diabetes.

This review shows that insulin analogs are cost-effective versus human insulins based on pharmacoeconomic models and retrospective database analyses. Objective: To examine the cost-effectiveness of ...

Various insulin regimens are used to treat patients with type 2 diabetes mellitus that is inadequately controlled by oral antidiabetic therapy. However, few studies have compared insulin regimens.

This is a preview. Log in through your library . Abstract When glucose is raised from a basal to stimulating level, the pancreatic islets respond with a typical biphasic insulin secretion pattern.

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics ...

Isolated adult rat pancreatic islets were dispersed into single cells and cultured free-floating for 3 to 4 d, during which time islet cells reaggregated spontaneously into spherical clusters or ...

A Consistent level 1 studies (e.g. a systematic review or well conducted RCT) B Consistent level 2 or 3 studies or extrapolations from level 1 studies (e.g. individual cohort studies or case-control ...

A major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater patient ...

A major international diabetes study of more than 52,000 patients from eight countries has shown that using biphasic BIAsp 30 insulin resulted in significant clinical improvements and greater patient ...